241 related articles for article (PubMed ID: 32041673)
1. Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling.
Liu Y; Zhang M; He T; Yang W; Wang L; Zhang L; Guo M
Clin Epigenetics; 2020 Feb; 12(1):22. PubMed ID: 32041673
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of JAM3 promotes esophageal cancer development by activating Wnt signaling.
Yang W; Guo C; Herman JG; Zhu C; Lv H; Su X; Zhang L; Zhang M; Guo M
Clin Epigenetics; 2022 Dec; 14(1):164. PubMed ID: 36461092
[TBL] [Abstract][Full Text] [Related]
3. Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer.
Du W; Gao A; Herman JG; Wang L; Zhang L; Jiao S; Guo M
Cancer Sci; 2021 Jul; 112(7):2870-2883. PubMed ID: 33931924
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development.
Wang Y; Zhang Y; Herman JG; Linghu E; Guo M
Oncotarget; 2017 Sep; 8(41):70035-70048. PubMed ID: 29050260
[TBL] [Abstract][Full Text] [Related]
5. Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.
Cao B; Yang W; Jin Y; Zhang M; He T; Zhan Q; Herman JG; Zhong G; Guo M
J Thorac Oncol; 2016 Nov; 11(11):1912-1926. PubMed ID: 27374455
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of RASSF10 promotes tumor growth in esophageal squamous cell carcinoma.
Lu D; Ma J; Zhan Q; Li Y; Qin J; Guo M
Discov Med; 2014 Apr; 17(94):169-78. PubMed ID: 24759621
[TBL] [Abstract][Full Text] [Related]
7. XAF1 is frequently methylated in human esophageal cancer.
Chen XY; He QY; Guo MZ
World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.
Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST
World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119
[TBL] [Abstract][Full Text] [Related]
10. Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling.
Zhang M; Linghu E; Zhan Q; He T; Cao B; Brock MV; Herman JG; Xiang R; Guo M
Oncotarget; 2016 Apr; 7(14):17957-69. PubMed ID: 26919254
[TBL] [Abstract][Full Text] [Related]
11. Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma.
Ma Y; He S; Gao A; Zhang Y; Zhu Q; Wang P; Yang B; Yin H; Li Y; Song J; Yue P; Li M; Zhang D; Liu Y; Wang X; Guo M; Jiao Y
Clin Epigenetics; 2020 Feb; 12(1):25. PubMed ID: 32046777
[TBL] [Abstract][Full Text] [Related]
12. Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling.
Zhu DS; Dong JY; Xu YY; Zhang XT; Fu SB; Liu W
Med Sci Monit; 2020 Aug; 26():e927106. PubMed ID: 32804918
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
[TBL] [Abstract][Full Text] [Related]
14. PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling.
Wang M; Gao M; Chen Y; Wu J; Wang X; Shu Y
BMC Cancer; 2023 Sep; 23(1):921. PubMed ID: 37773107
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes.
Smith P; Nicholson LJ; Syed N; Payne A; Hiller L; Garrone O; Occelli M; Gasco M; Crook T
Clin Cancer Res; 2007 Jul; 13(14):4061-8. PubMed ID: 17634530
[TBL] [Abstract][Full Text] [Related]
16. MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K/AKT/mTOR signaling pathway.
Guanen Q; Junjie S; Baolin W; Chaoyang W; Yajuan Y; Jing L; Junpeng L; Gaili N; Zhongping W; Jun W
Biomed Pharmacother; 2018 Sep; 105():350-361. PubMed ID: 29864623
[TBL] [Abstract][Full Text] [Related]
17. Silencing DACH1 promotes esophageal cancer growth by inhibiting TGF-β signaling.
Wu L; Herman JG; Brock MV; Wu K; Mao G; Yan W; Nie Y; Liang H; Zhan Q; Li W; Guo M
PLoS One; 2014; 9(4):e95509. PubMed ID: 24743895
[TBL] [Abstract][Full Text] [Related]
18. Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity.
Zhang W; Yan W; Qian N; Han Q; Zhang W; Dai G
Chin Med J (Engl); 2022 Feb; 135(5):606-618. PubMed ID: 35191417
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
Wang LQ; Wong KY; Rosèn A; Chim CS
Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
[TBL] [Abstract][Full Text] [Related]
20. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
Zhang J; Liu S; Zhang D; Ma Z; Sun L
J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
